Holen Sie sich die Stockscreener-App
27.20
0.33%
0.09
Handel nachbörslich:
27.19
-0.010
-0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt PHG?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$27.11
Offen:
$26.88
24-Stunden-Volumen:
743.16K
Relative Volume:
0.76
Marktkapitalisierung:
$25.88B
Einnahmen:
$20.19B
Nettoeinkommen (Verlust:
$1.03B
KGV:
25.45
EPS:
1.0687
Netto-Cashflow:
$966.68M
1W Leistung:
+2.53%
1M Leistung:
-5.98%
6M Leistung:
-3.00%
1J Leistung:
+23.19%
1-Tages-Spanne:
$26.86
$27.23
1-Wochen-Bereich:
$26.66
$27.62
52-Wochen-Spanne:
$21.48
$33.44
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Firmenname
Koninklijke Philips N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare PHG vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips N V Adr
|
27.20 | 25.79B | 20.19B | 1.03B | 966.68M | 1.0687 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-02-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-10-29 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-05-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Hochstufung | UBS | Sell → Neutral |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-01-17 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-09-06 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-06-16 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-14 | Hochstufung | HSBC Securities | Hold → Buy |
| 2022-01-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-08 | Eingeleitet | Jefferies | Buy |
| 2021-07-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-03-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Eingeleitet | Societe Generale | Buy |
| 2019-07-30 | Eingeleitet | Citigroup | Buy |
| 2018-02-12 | Hochstufung | Berenberg | Hold → Buy |
| 2017-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Herabstufung | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2016-12-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Eingeleitet | Citigroup | Buy |
| 2016-05-11 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2015-11-27 | Eingeleitet | ING Group | Hold |
| 2015-09-08 | Eingeleitet | Credit Suisse | Outperform |
| 2015-08-27 | Hochstufung | Nomura | Neutral → Buy |
| 2015-07-28 | Hochstufung | Societe Generale | Hold → Buy |
| 2011-01-25 | Herabstufung | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Hochstufung | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Herabstufung | UBS | Buy → Neutral |
Alle ansehen
Koninklijke Philips N V Adr Aktie (PHG) Neueste Nachrichten
IoT in Healthcare Market Led by Home-Care Segment Growing at an 18.32% CAGR; to Reach USD 483.72 Billion by 2031, Reports Mordor Intelligence - GlobeNewswire Inc.
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member - Sahm
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair - Finviz
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care - Finviz
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant - Sahm
Philips convenes the Annual General Meeting of Shareholders 2026 - Finviz
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment - Finviz
Koninklijke Philips (ADR) Stock Gains Traction as Earnings Beat Expectations Amid Health Tech Recove - AD HOC NEWS
PHIA Stock Price and Chart — EURONEXT:PHIA - TradingView
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite - Finviz
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 - Finviz
Philips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand direction - Finviz
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments - Finviz
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments - Finviz
Owlet Stock Before Q4 Earnings: Buy Now or Wait for Results? - Finviz
Philips introduces InkSpace Imaging's Snuggle flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort - Finviz
Philips (PHG) Soars to 52-Week High on Strong Earnings, Upbeat Outlook - Finviz
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments - Finviz
Earnings call transcript: Philips Q4 2025 earnings beat EPS forecasts - Investing.com
Philips proposes to re-appoint CEO Roy Jakobs - Finviz
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment - Finviz
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year - Finviz
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Price Over Earnings Overview: Koninklijke Philips - Sahm
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI - Finviz
Philips Bets On AI To See Inside Arteries With SpectraWAVE Buy - Sahm
Philips CEO Warns About 2026 Growth Target, Stock Drops - Sahm
AI-Powered Remote Electrocardiogram (ECG) Monitoring Market Report 2025 - GlobeNewswire Inc.
Koninklijke Philips N.V. (PHG): A Bull Case Theory - Finviz
Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy - Sahm
Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform - Finviz
Philips launches Verida, world's first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision - Finviz
Finanzdaten der Koninklijke Philips N V Adr-Aktie (PHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):